Nice to see you standing up for the Doc but you've totally missed the point. If you followed the tread the conversion was not around regulatory or clinical trial processes of drugs compared to devices.
The Doc clearly stated there is "different levels (or hierarchies) of evidence for surgical products vs medications." which is incorrect. I just found this amusing since he harps on about RCT as the gold standard - but applies a different filter to another stock he/she owns.
Classic!
Nice to see you standing up for the Doc but you've totally...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |